Skip to main content

Physician Sample Register: Receipt, Free Supply and Traceability

Keep physician samples identifiable as free sample stock from receipt to patient supply, quarantine or disposal. Record the exact product, pack quantity, batch, expiry, source and responsible recipient, then link any patient supply to an authorised clinical decision. Do not mix samples into ordinary saleable stock or hide a medicine charge inside another line. A free pack still needs traceability and a workable plan when it runs out.

By Bractis · Updated · 9 min read

Indian doctors and clinic teams receiving physician samples and organising their custody, patient supply and stock records under the applicable professional and regulatory arrangements.

Identify a physician sample before deciding how to record it

A representative may leave samples alongside promotional material or a commercial delivery. Identify the physical packs and their status before they enter the medicine shelf. A free sample, a purchased pack offered at a discount and a patient-returned item are different stock categories.

Rule 96(1)(ix) of the Drugs Rules specifies the additional label for drugs distributed to the medical profession as free samples. Preserve that status and the underlying product information. A sample should not become ordinary saleable stock because its receipt price in the software is zero.

Do not assume that every item given without an invoice is an acceptable sample. Establish the product identity, source, intended recipient and relevant restrictions. Unclear provenance, unreadable expiry or a damaged pack needs resolution before any patient supply.

The ledger proposed here is an original clinic control. It does not authorise sample receipt or dispensing by a particular person, and it does not replace the legal and professional rules governing the actual arrangement.

Source: CDSCO: Drugs Rules, 1945, compilation amended through July 2024

Separate the company's marketing obligations from the clinic's stock work

The Department of Pharmaceuticals' UCPMP 2024 contains conditions for companies providing free samples, including eligible recipients, marking and accountability. The official text reviewed for this guide includes September 2025 amendments. Its company disclosure rules should not be presented as a universal clinic register format.

Ask for usable delivery evidence identifying the company, product, quantity and receiving practitioner or authorised recipient. Record what physically arrived rather than copying the representative's proposed list. A signature on a delivery note should not imply endorsement of the product.

Keep the clinical selection independent of the sample cupboard. Availability can be relevant to an access discussion, but does not determine indication, formulation, duration or the patient's ongoing treatment. A promotional explanation is not a substitute for the clinician's assessment and reliable product information.

Where a commercial relationship creates a question about professional ethics, reporting or tax treatment, obtain the relevant advice rather than treating the stock ledger as a complete answer. This article does not calculate taxable benefits or interpret a company's annual marketing limits for a clinic.

Source: Department of Pharmaceuticals: UCPMP 2024, including September 2025 amendments

Use one movement history with a clearly separate sample balance

Create a distinct sample stock identity or category that remains visible on receipt, issue and export. Keep batch and expiry evidence attached even when the same product also exists as purchased stock. A common medicine catalogue can describe the product; it should not erase the different supply status.

The original table below follows a pack through the clinic. It is a working design, not a statutory form. Define both the pack count and its contents so later stock arithmetic does not switch silently between packs and tablets.

On a narrow screen, scroll the table horizontally to read all columns.

Original physician-sample movement record
StageEvidence to retainSeparate decision
ReceiptSource company, recipient, date, exact product, packs and contentsWhether receipt and product status are acceptable.
CustodyStorage location, batch, expiry and sample markingWhether stock is available, restricted or awaiting review.
Patient supplyPatient, authorised plan, actual quantity, date and responsible personWhether the medicine and amount are appropriate for this patient.
ContinuityWhat the free supply covers under the authorised planHow further care or supply will be arranged.
Restriction or disposalAffected packs, reason, decision and movement evidenceWhether stock may be used, returned or disposed of under the applicable process.

Show what was given free without concealing the clinical plan

Link the sample to the current prescription or authorised treatment record. Record the actual product and quantity handed over, with enough identity for the patient and the next clinician. 'Samples given' is too vague to support medication reconciliation or investigate a later concern.

Make the free supply clear to the patient. Do not bill the sample as an ordinary purchased medicine or disguise its sale value as a handling charge. Any genuinely separate consultation or service charge must remain understandable and follow the applicable rules; it must not conceal a charge for the sample.

Preserve manufacturer information and necessary labelling when using an outer packet. A small sample pack may contain fewer units than the patient expects from the familiar retail pack. Explain the actual contents and current instructions without inferring a treatment duration from the number supplied.

If only part of the authorised supply is available as samples, record the partial quantity and the remaining access question. Do not change the clinical course to match the cupboard. The responsible professional should decide how the patient will obtain or review the rest.

Plan for the day the samples are no longer available

A patient may assume that the same free product will be supplied at every visit. Explain what is being offered now and avoid a promise about future availability that the clinic cannot support. Document any agreed plan for review or subsequent supply.

Discuss affordability before the free pack runs out when it affects continuity. The clinician can consider appropriate options within the patient's circumstances. A sample-led initiation that later leaves the patient unable to obtain treatment is a problem to anticipate, not simply a stockout to record.

Keep brand, strength and formulation changes subject to the appropriate clinical review. A later purchased pack may look different from the sample; the patient needs a clear identity and instruction link. Staff should not substitute another sample merely because its packaging or claimed purpose looks similar.

Give a usable patient copy where needed. The person should be able to tell another clinician or pharmacist what was supplied, even if the outer carton has been discarded. Record uncertain outside use as uncertain instead of assuming that the sample was taken exactly as planned.

Count packs and units without mixing samples with sales

In a fictional ledger, five sample packs are already held and three more are received. Each contains six tablets, giving eight packs or 48 tablets. Four packs are supplied to patients, one pack is quarantined and three remain available.

The available balance is three packs or 18 tablets. Physical custody is four packs or 24 tablets because the quarantined pack is still on site. The patient supply is four packs or 24 tablets. These totals reconcile, but they describe different states.

Keep sample movements out of ordinary sales-volume and purchase-margin reports unless the report explicitly distinguishes them. Zero acquisition price does not mean a 100% commercial margin, and free patient supply should not be counted as a paid medicine sale.

Investigate differences using receipt, supply and disposition evidence. If one pack cannot be located, record the discrepancy and owner. Do not create a fictional patient supply merely to balance the shelf, or erase an earlier issue when a product later enters quarantine.

Make sample stock findable during a recall or complaint

A batch concern may affect both purchased and sample packs. Search by the actual product and batch across stock categories, then identify remaining material and patient supply events separately. A system that searches only invoiced medicines can miss the free packs already handed out.

Keep patient care, reporting and stock restriction coordinated but distinct. The clinician assesses the patient's situation; the responsible stock process handles affected material; any applicable reporting follows its own route. A sample ledger supports those actions without determining causation.

Review a few real movements periodically: receipt to shelf, shelf to patient, and restriction to disposition. Include a sample with a changed pack size or an unclear recipient. The review should reveal whether the record works under exceptions, not merely confirm that a spreadsheet exists.

For software evaluation, use the same fictional product as both purchased and sample stock. Check whether the sample marking, balances, free patient issue and batch search remain clear in screens and exports. Ask which controls are built in and which require an explicit local procedure.

The same batch in two stock categories

In a fictional clinic, a batch alert concerns a product held as purchased stock and as physician samples. The team finds both categories and identifies the patients who received free packs as well as paid supplies. The clinical response and authorised stock disposition are recorded separately. A search restricted to invoices would have missed the sample recipients even though the physical medicine came from the same affected batch.

Physician Sample Movement Worksheet

Use these prompts in your clinic’s own notes. Record the result, responsible person and next action for each item.

Receipt evidence
Verify the actual source, recipient, sample marking, product and quantity received.
Free supply
Trace a sample to the authorised patient plan and actual quantity without a hidden medicine charge.
Continuity
Identify how the patient obtains advice or further supply when the free packs end.
Stock reconciliation
Count available, quarantined and issued sample packs and test a batch search across stock categories.

Questions doctors ask

Can physician samples be mixed with ordinary saleable inventory?

Keep their sample status and movement history distinct. Shared product identity can help searches, but receipt, free patient supply and restricted balances must remain recognisable. A zero purchase price does not convert a sample into normal commercial stock.

Should free samples appear in the patient's medicine record?

Yes, when actually supplied, record the exact product and quantity with the authorised plan and source evidence. A generic note saying samples given is inadequate for later medicine reconciliation or batch investigation.

Is the UCPMP company disclosure form the clinic's sample register?

No. The company's marketing-accountability obligations and the clinic's physical receipt, custody and patient-supply records serve different purposes. The ledger here is an original operational model, not a replacement for applicable duties.

Does the sample pack size determine the treatment course?

No. The responsible clinician determines the plan. Record any partial free supply and address the remaining access need without changing the regimen to fit the available pack.

How should a clinic respond when a sample batch is affected by an alert?

Identify affected stock and patient supply through the batch record, then follow the applicable clinical, reporting and authorised stock-response processes. Free supply should remain as traceable as other medicine supply.

Sources and scope

Updated on . This guide distinguishes published sample-marking and company marketing provisions from an original clinic ledger. It does not determine receipt eligibility, dispensing authority, tax treatment or a patient regimen. No independent clinical or legal review is claimed.

Try the workflow
with Bractis.

Use fictional purchased and sample stock for the same product to inspect free supply, separate balances, patient links and batch retrieval in the available workflow.

Request a clinic demo